FARAH NABIL; SALEEM, Mohammed. First-Line FOLFIRINOX vs Gemcitabine ± Nab-Paclitaxel in Metastatic Pancreatic Adenocarcinoma: Real-World Treatment Response and Clinicopathologic Predictors from a 2022 Tertiary-Center Cohort. Middle Eastern Cancer and Oncology Journal, [S. l.], v. 2, n. 2, p. 11–17, 2026. DOI: 10.61706/MECOJ160191. Disponível em: https://scientificsteps-group.com/ojs/ojs3/index.php/mecoj/article/view/191. Acesso em: 28 may. 2026.